Pharmacokinetic Study of Single-Dose Modified Release Glipizide in Healthy Volunteers

Recruiting

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

United States

University of Michigan, Ann Arbor, Michigan

18 Years – 55 Years

Last updated March 2026